Animal models of chronic obstructive pulmonary disease exacerbations

Contributions to Microbiology

Volumn 14, Issue , 2007, Pages 126-141

  Gaschler, G ^a   Bauer, C ^a   Zavitz, C ^a   Stampfli M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS);

ANIMAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE MODEL; HUMAN; IMMUNOLOGY; MICROBIOLOGY; REVIEW; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 35848948855     PISSN: 14209519     EISSN: 1662291X     Source Type: Book Series    
DOI: 10.1159/000107059     Document Type: Review

References (98)

1. Rodriguez-Roisin R: Toward a consensus definition for COPD exacerbations. Chest 2000;117:398S-401S.
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
3. Hogg JC: Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364:709-721.
4. Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:S28-S38.
5. Snider GL: Chronic obstructive pulmonary disease: a definition and implications of structural determinants of airflow obstruction for epidemiology. Am Rev Respir Dis 1989;140:S3-S8.
6. Wright JL, Churg A: Animal models of cigarette smoke-induced COPD. Chest 2002;122:301S-306S.
7. Vlahos R, Bozinovski S, Gualano RC, Ernst M, Anderson GP: Modelling COPD in mice. Pulm Pharmacol Ther 2006;19:12-17.
8. Mallia P, Johnston SL: Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations. Proc Am Thorac Soc 2005;2:361-366, 371-372.
9. Mahadeva R, Shapiro SD: Chronic obstructive pulmonary disease * 3: experimental animal models of pulmonary emphysema. Thorax 2002;57:908-914.
10. Groneberg DA, Chung KF: Models of chronic obstructive pulmonary disease. Respir Res 2004;5:18.
11. Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriguez-Roisin R: Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-1505.
12. Sethi S, Murphy TF: Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin Microbiol Rev 2001;14:336-363.
13. Wedzicha JA: Role of viruses in exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:115-120.
14. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-1121.
15. Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD: Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health 2005;4:7.
16. Calverley PM: Reducing the frequency and severity of exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:121-124.
17. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA: Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-764.
18. Puchelle E, Zahm JM, Tournier JM, Coraux C: Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:726-733.
19. Murphy TF, Sethi S, Klingman KL, Brueggemann AB, Doern GV: Simultaneous respiratory tract colonization by multiple strains of nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease: implications for antibiotic therapy. J Infect Dis 1999;180:404-409.
20. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA: Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000;109:288-295.
21. Cabello H, Torres A, Celis R, El-Ebiary M, Puig de la Bellacasa J, Xaubet A, Gonzalez J, Agusti C, Soler N: Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997;10:1137-1144.
22. Sethi S, Evans N, Grant BJ, Murphy TF: New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-471.
23. Sethi S, Wrona C, Grant BJ, Murphy TF: Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169:448-453.
24. Verra F, Escudier E, Lebargy F, Bernaudin JF, De Cremoux H, Bignon J: Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med 1995;151:630-634.
25. Honda Y, Takahashi H, Kuroki Y, Akino T, Abe S: Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers. Chest 1996;109:1006-1009.
26. Subramaniam S, Whitsett JA, Hull W, Gairola CG: Alteration of pulmonary surfactant proteins in rats chronically exposed to cigarette smoke. Toxicol Appl Pharmacol 1996;140:274-280.
27. Twigg HL 3rd, Soliman DM, Spain BA: Impaired alveolar macrophage accessory cell function and reduced incidence of lymphocytic alveolitis in HIV-infected patients who smoke. Aids 1994;8:611-618.
28. Ortega E, Hueso F, Collazos ME, Pedrera MI, Barriga C, Rodriguez AB: Phagocytosis of latex beads by alveolar macrophages from mice exposed to cigarette smoke. Comp Immunol Microbiol Infect Dis 1992;15:137-142.
29. Ortega E, Barriga C, Rodriguez AB: Decline in the phagocytic function of alveolar macrophages from mice exposed to cigarette smoke. Comp Immunol Microbiol Infect Dis 1994;17:77-84.
30. Ohta T, Yamashita N, Maruyama M, Sugiyama E, Kobayashi M: Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages. Respir Med 1998;92:922-927.
31. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD: Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994;150:696-703.
32. King TE Jr, Savici D, Campbell PA: Phagocytosis and killing of Listeria monocytogenes by alveolar macrophages: smokers versus nonsmokers. J Infect Dis 1988;158:1309-1316.
33. Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M: Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 2003;81:289-296.
34. Hagiwara E, Takahashi KI, Okubo T, Ohno S, Ueda A, Aoki A, Odagiri S, Ishigatsubo Y: Cigarette smoking depletes cells spontaneously secreting Th(1) cytokines in the human airway. Cytokine 2001;14:121-126.
35. Berenson CS, Wrona CT, Grove LJ, Maloney J, Garlipp MA, Wallace PK, Stewart CC, Sethi S: Impaired alveolar macrophage response to haemophilus antigens in chronic obstructive lung disease. Am J Respir Crit Care Med 2006;174:31-40.
36. Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S: Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 2006;194:1375-1384.
37. Burns AR, Hosford SP, Dunn LA, Walker DC, Hogg JC: Respiratory epithelial permeability after cigarette smoke exposure in guinea pigs. J Appl Physiol 1989;66:2109-2116.
38. Boucher RC, Johnson J, Inoue S, Hulbert W, Hogg JC: The effect of cigarette smoke on the permeability of guinea pig airways. Lab Invest 1980;43:94-100.
39. Meng QR, Gideon KM, Harbo SJ, Renne RA, Lee MK, Brys AM, Jones R: Gene expression profiling in lung tissues from mice exposed to cigarette smoke, lipopolysaccharide, or smoke plus lipopolysaccharide by inhalation. Inhal Toxicol 2006;18:555-568.
40. Thomas WR, Holt PG, Keast D: Cigarette smoke and phagocyte function: effect of chronic exposure in vivo and acute exposure in vitro. Infect Immun 1978;20:468-475.
41. Rylander R, Wold A, Haglind P: Nasal antibodies against gram-negative bacteria in cotton-mill workers. Int Arch Allergy Appl Immunol 1982;69:330-334.
42. Ozlu T, Cay M, Akbulut A, Yekeler H, Naziroglu M, Aksakal M: The facilitating effect of cigarette smoke on the colonization of instilled bacteria into the tracheal lumen in rats and the improving influence of supplementary vitamin E on this process. Respirology 1999;4:245-248.
43. Laurenzi GA, Guarneri JJ, Endriga RB, Carey JP: Clearance of bacteria by the lower respiratory tract. Science 1963;142:1572-1573.
44. Drannik AG, Pouladi MA, Robbins CS, Goncharova SI, Kianpour S, Stampfli MR: Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2004;170:1164-1171.
45. Parks WC, Wilson CL, Lopez-Boado YS: Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-629.
46. Parks WC, Shapiro SD: Matrix metalloproteinases in lung biology. Respir Res 2001;2:10-19.
47. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD: Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997;277:2002-2004.
48. Janoff A, Sloan B, Weinbaum G, Damiano V, Sandhaus RA, Elias J, Kimbel P: Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 1977;115:461-478.
49. Churg A, Wang RD, Tai H, Wang X, Xie C, Dai J, Shapiro SD, Wright JL: Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. Am J Respir Crit Care Med 2003;167:1083-1089.
50. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD: Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006;116:753-759.
51. Inoue S, Nakamura H, Otake K, Saito H, Terashita K, Sato J, Takeda H, Tomoike H: Impaired pulmonary inflammatory responses are a prominent feature of streptococcal pneumonia in mice with experimental emphysema. Am J Respir Crit Care Med 2003;167:764-770.
52. Hansen EJ, Toews GB: Animal models for the study of noninvasive Haemophilus influenzae disease: pulmonary clearance systems. J Infect Dis 1992;165(suppl 1):S185-S187.
53. Chin CL, Manzel LJ, Lehman EE, Humlicek AL, Shi L, Starner TD, Denning GM, Murphy TF, Sethi S, Look DC: Haemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizers. Am J Respir Crit Care Med 2005;172:85-91.
54. Kadioglu A, Taylor S, Iannelli F, Pozzi G, Mitchell TJ, Andrew PW: Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect Immun 2002;70:2886-2890.
55. Stark JM, Stark MA, Colasurdo GN, LeVine AM: Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection. J Med Virol 2006;78:829-838.
56. van Heeckeren AM, Schluchter MD: Murine models of chronic Pseudomonas aeruginosa lung infection. Lab Anim 2002;36:291-312.
57. Yanagihara K, Tomono K, Sawai T, Hirakata Y, Kadota J, Koga H, Tashiro T, Kohno S: Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 1997;155:337-342.
58. Bakshi CS, Malik M, Carrico PM, Sellati TJ: T-bet deficiency facilitates airway colonization by Mycoplasma pulmonis in a murine model of asthma. J Immunol 2006;177:1786-1795.
59. Zhu D, Barniak V, Zhang Y, Green B, Zlotnick G: Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis. Vaccine 2006;24:5420-5425.
60. Heininger U, Cotter PA, Fescemyer HW, Martinez de Tejada G, Yuk MH, Miller JF, Harvill ET: Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect Immun 2002;70:3777-3784.
61. Harvill ET, Cotter PA, Miller JF: Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect Immun 1999;67:6109-6118.
62. Kirimanjeswara GS, Mann PB, Harvill ET: Role of antibodies in immunity to Bordetella infections. Infect Immun 2003;71:1719-1724.
63. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, Jeffery PK: Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:968-975.
64. Tan WC, Xiang X, Qiu D, Ng TP, Lam SF, Hegele RG: Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003;115:272.
65. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G: Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 2003;58:37-42.
66. Busse WW: Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J Allergy Clin Immunol 1990;85:671-683.
67. Makela MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimaki M, Blomqvist S, Hyypia T, Arstila P: Viruses and bacteria in the etiology of the common cold. J Clin Microbiol 1998;36:539-542.
68. Bella J, Rossmann MG: Review: rhinoviruses and their ICAM receptors. J Struct Biol 1999;128:69.
69. Nicholson KG, Kent J, Hammersley V: Influenza A among community-dwelling elderly persons in Leicestershire during winter 1993-4; cigarette smoking as a risk factor and the efficacy of influenza vaccination. Epidemiol Infect 1999;123:103-108.
70. Barnes MC, Streips UN, Sonnenfeld G: Effect of carcinogens and analogs on interferon induction. Oncology 1981;38:98-101.
71. Sonnenfeld G: Effect of sidestream tobacco smoke components on alpha/beta interferon production. Oncology 1983;40:52-56.
72. Sonnenfeld G, Hudgens RW: Effect of sidestream and mainstream smoke exposure on in vitro interferon-alpha/beta production by L-929 cells. Cancer Res 1986;46:2779-2783.
73. Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies WA, Hogg JC: Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992;146:177-184.
74. Elliott WM, Hayashi S, Hogg JC: Immunodetection of adenoviral E1A proteins in human lung tissue. Am J Respir Cell Mol Biol 1995;12:642-648.
75. Retamales I, Elliott WM, Meshi B, Coxson HO, Pare PD, Sciurba FC, Rogers RM, Hayashi S, Hogg JC: Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001;164:469-473.
76. Meshi B, Vitalis TZ, Ionescu D, Elliott WM, Liu C, Wang XD, Hayashi S, Hogg JC: Emphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory response. Am J Respir Cell Mol Biol 2002;26:52-57.
77. Robbins CS, Dawe DE, Goncharova SI, Pouladi MA, Drannik AG, Swirski FK, Cox G, Stampfli MR: Cigarette smoke decreases pulmonary dendritic cells and impacts antiviral immune responsiveness. Am J Respir Cell Mol Biol 2004;30:202-211.
78. Behzad AR, Morimoto K, Gosselink J, Green J, Hogg JC, Hayashi S: Induction of mesenchymal cell phenotypes in lung epithelial cells by adenovirus E1A. Eur Respir J 2006;28:1106-1116.
79. Jefferson T: Influenza vaccination: policy versus evidence. BMJ 2006;333:912-915.
80. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, Demicheli V: Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006;3:CD004876.
81. Robbins CS, Bauer CMT, Vujicic N, Gaschler GJ, Lichty BD, Brown EG, Stampfli MR: Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am J Respir Crit Care Med 2006;174:1342-1351.
82. Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, Jeffery PK: Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;168:968-975.
83. Gump DW, Phillips CA, Forsyth BR, McIntosh K, Lamborn KR, Stouch WH: Role of infection in chronic bronchitis. Am Rev Respir Dis 1976;113:465-474.
84. Smith CB, Golden C, Klauber MR, Kanner R, Renzetti A: Interactions between viruses and bacteria in patients with chronic bronchitis. J Infect Dis 1976;134:552-561.
85. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL: Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-1121.
86. Cameron RJ, de Wit D, Welsh TN, Ferguson J, Grissell TV, Rye PJ: Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 2006;32:1022-1029.
87. Wilkinson TM, Hurst JR, Perera WR, Wilks M, Donaldson GC, Wedzicha JA: Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD. Chest 2006;129:317-324.
88. Wadowsky RM, Mietzner SM, Skoner DP, Doyle WJ, Fireman P: Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect Immun 1995;63:1153-1157.
89. LeVine AM, Koeningsknecht V, Stark JM: Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods 2001;94:173-186.
90. Takase H, Nitanai H, Yamamura E, Otani T: Facilitated expansion of pneumococcal colonization from the nose to the lower respiratory tract in mice preinfected with influenza virus. Microbiol Immunol 1999;43:905-907.
91. Avadhanula V, Rodriguez CA, Devincenzo JP, Wang Y, Webby RJ, Ulett GC, Adderson EE: Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J Virol 2006;80:1629-1636.
92. Hament JM, Aerts PC, Fleer A, van Dijk H, Harmsen T, Kimpen JL, Wolfs TF: Direct binding of respiratory syncytial virus to pneumococci: a phenomenon that enhances both pneumococcal adherence to human epithelial cells and pneumococcal invasiveness in a murine model. Pediatr Res 2005;58:1198-1203.
93. Jakab GJ, Green GM: Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs. J Clin Invest 1976;57:1533-1539.
94. Jakab GJ, Green GM: The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung. J Clin Invest 1972;51:1989-1998.
95. Qureshi MH, Garvy BA, Pomeroy C, Inayat MS, Oakley OR: A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression. Virus Res 2005;114:35-44.
96. Huang CC, Shah S, Nguyen P, Altman JD, Blackman MA: Bacterial superantigen exposure after resolution of influenza virus infection perturbs the virus-specific memory CD8(+)-T-cell repertoire. J Virol 2002;76:6852-6856.
97. Sajjan US, Jia Y, Newcomb DC, Bentley JK, Lukacs NW, LiPuma JJ, Hershenson MB: H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression. FASEB J 2006;20:2121-2123.
98. Seki M, Higashiyama Y, Tomono K, Yanagihara K, Ohno H, Kaneko Y, Izumikawa K, Miyazaki Y, Hirakata Y, Mizuta Y, Tashiro T, Kohno S: Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin Exp Immunol 2004;137:35-40.